REGENERON PHARMACEUTICALS, INC. (REGN)
Healthcare · Pharmaceutical Preparations
REGENERON PHARMACEUTICALS, INC. (REGN) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q3)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| Robeco Institutional Asset Management B.V. | 402,958 | $305.55M | 0.43% |
| Sumitomo Mitsui Trust Group, Inc. | 278,120 | $210.89M | 0.29% |
| Swedbank AB | 188,572 | 42.99M | 0.20% |
| KBC Group NV | 188,496 | 42.9K | 0.20% |
| Candriam S.C.A. | 173,146 | 31.77M | 0.18% |
| MCDONALD CAPITAL INVESTORS INC/CA | 172,649 | 30.91M | 0.18% |
| Pictet Asset Management Holding SA | 129,108 | $97.24M | 0.14% |
| MACKENZIE FINANCIAL CORP | 127,797 | $96.90M | 0.14% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-10-30 | Guarini Kathryn | Director | Sale | $360.0K |
| 2026-10-30 | McCourt Marion | EVP Commercial | Sale | $984.2K |
| 2026-10-30 | BROWN MICHAEL S | Director | Sale | .69M |
| 2026-10-14 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sale | $20.6K |
| 2026-10-14 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sale | $26.5K |
| 2026-10-14 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sale | $4.5K |
| 2026-10-14 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sale | 0.6K |
| 2026-10-14 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sale | 2.1K |